Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

OfficeHours

AUGUST 20, 2023

Once improved, the exit can then take place, usually in the form of another sale or an Initial Public Offering (IPO), both of which are usually under the advice of an investment bank. You must be able to consider long-term goals, assess risk, and craft plans to enhance the value of portfolio companies.

Private Equity 130

Private Equity Equities Investment Banking Finance 130

Cooley M&A

JANUARY 23, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Why did life sciences outperform the market? The last quarter of the year ended with a surge of deal activity. billion, Mirati for $5.8

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Cooley M&A

SEPTEMBER 16, 2022

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. Bill Roegge. Meredith Klionsky. Teddy Nimetz. [1] Dual-class companies that emerged in other contexts (e.g.,

M&A 59

M&A IPO Shares Mergers and Acquisitions 59

Cooley M&A

JANUARY 25, 2023

Tech M&A in 2022 was a tale of two halves. billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 trillion. [2] trillion.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Focus Investment Banking

NOVEMBER 18, 2024

This active M&A market continued for almost three years until mid-to-late 2022 when interest rates increased rapidly, making it much more expensive to buy or build new car wash locations. Alternative Solutions: I would expect to see other alternative options used by certain platforms to extend their hold periods.

Private Equity 52

Private Equity Equities IPO Valuation 52

Cooley M&A

JANUARY 22, 2025

This stands in stark contrast to 2023, when life sciences M&A outperformed the market with a 50% increase in deal value from 2022 compared to a 17% decline in overall M&A activity across all industries. Luckily, theres more to this years story.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64